NUCLEIC ACID INSIGHTS

Bioconjugation Insights

Bioconjugation Insights is an online, open access, peer-reviewed journal with an interdisciplinary, translational focus on all aspects and areas of the bioconjugation field, including ADCs, oligonucleotide conjugates, protein and peptide conjugates, PEGylation, radioconjugates, conjugated vaccines, diagnostics, and more.

Bioconjugation Insights is designed to provide the understanding and need-to-know information required to navigate this rapidly advancing sector. It serves as the go-to online resource for the latest news, trends, challenges, and breakthroughs in bioconjugation.

We address critical challenges and highlight the latest developments in bioconjugation, publishing original research articles, expert reviews, commentary, case studies, and more. Visit the Bioconjugation Insights Journal page for our comprehensive collection.

Our informative webinar series offers expert-led discussions on significant breakthroughs, novel methodologies, and strategic insights, aimed at supporting continued professional growth and innovation in bioconjugation.

Explore our content for targeted insights into key areas, including conjugation chemistry, analytics, manufacturing processes, and regulatory considerations essential to effective bioconjugate development.

Learn more about our journal’s mission, scope, and publication guidelines by visiting our detailed aims and scope.

Sign-up for free to access our extensive library of articles, webinars, podcasts, news, and interviews, and stay at the forefront of bioconjugation innovation.

If you’re interested in collaborating through sponsorship opportunities, webinars, articles, or other initiatives, please view our media kit to learn more.

Cell and Gene Therapy Insights

Cell & Gene Therapy Insights is an online, open-access, peer-reviewed journal dedicated to the interdisciplinary exploration and advancement of cell and gene therapy. With a translational focus, we connect innovative research to practical clinical applications, providing valuable insights into one of biotechnology’s fastest-evolving fields.

We address the key challenges and latest developments across advanced therapies, publishing original research articles, expert reviews, commentary, clinical trial reports, and more. Visit the Cell & Gene Therapy Insights Journal page for our complete collection.

Our popular webinar series provides expert-led discussions on important developments and methodologies in the field, designed to support ongoing professional growth.

Explore our specialised channels, including detailed coverage of critical areas like the cell and gene supply chain, for targeted insights into manufacturing, logistics, and regulatory frameworks essential to therapy commercialisation.

Learn more about our journal’s mission and publishing criteria by visiting our aims and scope.

Sign-up for free to gain unlimited access to our extensive library of articles, webinars, podcasts, news, and interviews, and stay at the forefront of cell and gene therapy innovation.

If you’re interested in working with us, from sponsoring articles to webinars and more, view the media kit to find out more.

Vaccine Insights

Vaccine Insights is an online, open-access, peer-reviewed journal focused on advances and innovation within vaccine R&D and manufacturing.

Guided by an expert advisory board, the journal brings together leading experts from pharma, biotech, academia, and other key stakeholders to address critical issues and put the latest developments into context.

We address key challenges and explore the latest advances in vaccine development, production, and supply, publishing reviews, commentary, original research articles, and more.. Visit the Vaccine Insights Journal page to access our full collection.

Our informative webinar series provides expert-led discussions covering major developments, emerging technologies, and strategic considerations, designed to foster continued professional growth and collaboration in vaccine science.

Explore our specialised channels for targeted insights into critical areas, including dedicated immune response and clinical update channels essential for effective vaccine development and deployment.

Learn more about our journal’s aims, scope, and publishing guidelines by visiting our detailed aims and scope.

Sign-up for free to gain unlimited access to our extensive collection of articles, webinars, podcasts, news, and interviews, and remain at the forefront of vaccine innovation.

If you’re interested in partnering with us through sponsored content, webinars, articles, or other collaborations, please view our media kit to find out more.

Closed Publications

Immuno-oncology Insights

Immuno-Oncology Insights has ceased publication. However, all published content remains available here.


Immuno-Oncology Insights was an open access, independently peer reviewed publication specifically designed to fill a number of clear and important gaps in the slate of journals for the industrial and academic and immuno-oncology communities.


Guided by an editorial board lead by Jon Wigginton and Renier J Brentjens, Immuno-Oncology Insights placed R&D and manufacturing challenges and progress across a wide variety of technology fields in context.

 

To find out more or to access some of our fantastic content, visit Immuno-Oncology Insights.